They included 314 eyes between January 2006 to December 2016 to compare the outcome of primary intravitreal anti-VEGF treatment and laser photocoagulation for ROP; among those, 161 eyes were treated with laser treatment primarily and 153 eyes were treated with intravitreal anti-VEGF injection primarily. The gene discussed is VEGFA; the disease is retinopathy of prematurity.